(2) To sustain the in vivo effect of joint TNFα + Ras hyper-activation (RasG12V) in inducing the release of multiple pro-tumorigenic factors by the tumor cells, we have introduced a previously described approach [61,62], in which tumors were inoculated with tumor cell products throughout the process of tumor growth. This evidence concerns the gene TNF and neoplasm.